Dr. Hascup at work in the lab

Dale and Deborah Smith Center for Alzheimer's Research and Treatment

Remote video URL
RESEARCH, PATIENT CARE

Gift offers renewed hope

A major gift to Southern Illinois University School of Medicine will transform the health care of people throughout Illinois and beyond. Dale and Deborah Smith recently donated a substantial financial gift to the Center for Alzheimer’s Disease and Related Disorders at SIU Medicine to expand research, enhance programming and improve care for people with Alzheimer’s disease and assist their caregivers.

Learn more

PATIENT CARE

Beyond the Medical Center

While the researchers at the Smith Alzheimer’s Center investigate new and better ways to prevent, slow, and cure dementia-related diseases, our team is caring for and supporting patients and their families through free, therapeutic, evidence-based programs to improve quality of life.

These programs are designed not only for those with Alzheimer’s, using creativity through art, music, exercise and more, but also for the individuals caring for them, equipping family caregivers with resources and skills. 

Elderly man smiling
Image
White-Coats-Horizontal

A disease without a cure

Alzheimer's disease impacts families everywhere. Here at SIU Medicine, the newly renamed Dale and Deborah Smith Center for Alzheimer's Research and Treatment is trying to find ways to slow the progression of the disease. Learn more about our research and programs related to Alzheimer's in this Medicine Minute with Erin Hascup, PhD, director of the center.

Medicine Minute | Erin Hascup

Remote video URL

Latest news

Introducing the Dale and Deborah Smith Center

A major gift to SIU School of Medicine will transform the health care of people throughout Illinois and beyond. Springfield couple Dale and Deborah Smith donated a substantial financial gift to the
Bain Scan

SIU School of Medicine receives major gift for Alzheimer's research

A major gift to Southern Illinois University School of Medicine will transform the health care of people throughout Illinois and beyond. Dale and Deborah Smith recently donated a substantial financial

New study looks at use of Riluzole to slow Alzheimer's progression

Riluzole is an FDA-approved drug, currently used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease) and is currently in a Phase II clinical trial for the treatment of mild Alzheimer’s

SIU Medicine Group to Study COVID’s Potential Effects on Alzheimer’s

Medical researchers at SIU School of Medicine’s Neuroscience Institute are studying how the novel coronavirus may accelerate the progression of Alzheimer’s disease. Their data could help identify